Sacituzumab Govitecan Toxicity Outcomes In Arab Patients with Metastatic Breast Cancer

被引：0
|
作者：
Altarturi, Maymouna
Suleman, Kausar
AlSayed, Adhar
Al-Shamsi, Humaid
Alawadhi, Aydah
Basuliamn, Bassam
Alaklabi, Sabah
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 09期
关键词：
D O I：
10.1158/1538-7445.SABCS23-PO4-12-10
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO4-12-10
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
    Bardia, A.
    Mayer, I. A.
    Vahdat, L. T.
    Tolaney, S. M.
    Isakoff, S. J.
    Diamond, J. R.
    O'Shaughnessy, J.
    Moroose, R. L.
    Santin, A. D.
    Abramson, V. G.
    Shah, N. C.
    Rugo, H. S.
    Goldenberg, D. M.
    Sweidan, A. M.
    Iannone, R.
    Washkowitz, S.
    Sharkey, R. M.
    Wegener, W. A.
    Kalinsky, K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (08): : 741 - 751
  • [22] Population Pharmacokinetics of Sacituzumab Govitecan in Patients with Metastatic Triple-Negative Breast Cancer and Other Solid Tumors
    Abhishek G. Sathe
    Indrajeet Singh
    Pratap Singh
    Paul M. Diderichsen
    Xiaohui Wang
    Peter Chang
    Atiya Taqui
    See Phan
    Sandhya Girish
    Ahmed A. Othman
    Clinical Pharmacokinetics, 2024, 63 : 669 - 681
  • [23] Sacituzumab govitecan in triple-negative breast cancer
    de Nonneville, Alexandre
    Goncalves, Anthony
    Mamessier, Emilie
    Bertucci, Francois
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (11)
  • [24] Sacituzumab govitecan in HR+ and HER2-metastatic breast cancer: for all or for some?
    Loibl, Sibylle
    Holtschmidt, Johannes
    LANCET, 2023, 402 (10411): : 1394 - 1395
  • [25] Sacituzumab Govitecan in HR-positive HER2-negative metastatic breast cancer
    Nardin, Simone
    Del Mastro, Lucia
    ANNALS OF TRANSLATIONAL MEDICINE, 2023,
  • [26] Sacituzumab Govitecan: A Review in Unresectable or Metastatic HR+/HER2− Breast Cancer
    Connie Kang
    Targeted Oncology, 2024, 19 : 289 - 296
  • [27] Real-World outcomes with sacituzumab govitecan among breast cancer patients with central nervous system metastases
    Thomas Grinda
    Stefania Morganti
    Liangge Hsu
    Tae-Kyung Yoo
    Ross J. Kusmick
    Ayal A. Aizer
    Antonio Giordano
    Jose P. Leone
    Melissa Hughes
    Sara M. Tolaney
    Nancy U. Lin
    Sarah L. Sammons
    npj Breast Cancer, 11 (1)
  • [28] Sacituzumab govitecan: a new opportunity in the treatment of refractory metastatic triple-negative breast cancer
    Maltoni, Roberta
    Bravaccini, Sara
    ANNALS OF TRANSLATIONAL MEDICINE, 2022, 10 (07)
  • [29] Sacituzumab Govitecan: A Review in Unresectable or Metastatic HR+/HER2-Breast Cancer
    Kang, Connie
    TARGETED ONCOLOGY, 2024, 19 (02) : 289 - 296
  • [30] An integrated analysis of Sacituzumab govitecan in relapsed or refractory metastatic triple-negative breast cancer
    Cheng, Shao-Xian
    Chen, Qiu-Chi
    Lin, Guo-He
    Han, Yan-Hong
    Wang, Bi-Cheng
    Dai, Yi
    Zhao, Yan-Xia
    MEDICINE, 2023, 102 (30) : E34486
12345